604: A Phase I Trial of Vaccination of Personalized Peptides for HLA-A2/A24 Positive Patients with Hormone-Refractory Prostate Cancer

2007 ◽  
Vol 177 (4S) ◽  
pp. 202-202
Author(s):  
Hirotsugu Uemura ◽  
Motoyoshi Tanaka ◽  
Shigeya Uejima ◽  
Takafumi Minami ◽  
Kiyohide Fujimoto ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

scholarly journals Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer

Cancer ◽  
2006 ◽  
Vol 106 (9) ◽  
pp. 1917-1924 ◽  
Author(s):  
George Wilding ◽  
Patrick Soulie ◽  
Donald Trump ◽  
Ashis Das-Gupta ◽  
Eric Small
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Pilot Phase ◽  
Hormone Refractory

Phase I Trial of Oral Estramustine and 3-hr Infusional Paclitaxel for the Treatment of Hormone Refractory Prostate Cancer

2002 ◽  
Vol 20 (5-6) ◽  
pp. 634-643 ◽  
Author(s):  
Timothy M. Kuzel ◽  
Merrill S. Kies ◽  
Nini Wu ◽  
Yi-Ching Hsieh ◽  
Alfred W. Rademaker
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

A Phase I Trial of Docetaxel/Estramustine/Imatinib in Patients with Hormone-Refractory Prostate Cancer

2007 ◽  
Vol 5 (5) ◽  
pp. 323-328 ◽  
Author(s):  
Amy M. Lin ◽  
Brian I. Rini ◽  
Mika K. Derynck ◽  
Vivian Weinberg ◽  
Margaret Park ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory
Sign in / Sign up

Export Citation Format

Share Document